When will the US Food and Drug Administration (FDA) approve MDMA (aka midomafetamine or ecstasy) for marketing in the US?

Started Dec 15, 2023 06:00PM UTC
Closing Dec 14, 2024 08:01AM UTC
Challenges

MAPS Public Benefit Corporation announced on 12 December 2023 that it submitted a new drug application (NDA) to the FDA for MDMA to be used in mental health therapy (MAPS Public Benefit Corp., Drug Bank - Midomafetamine, FDA - Drug Approval Process). The type of approval (e.g., Standard, Accelerated) is immaterial (FDA - Development & Approval Process). For the purposes of this question, any rescheduling of MDMA by the Drug Enforcement Administration is immaterial.

Confused? Check our FAQ or ask us for help. To learn more about Good Judgment and Superforecasting, click here.

To learn more about how you can become a Superforecaster, see hereFor other posts from our Insights blog, click here.

Possible Answer Crowd Forecast Change in last 24 hours Change in last week Change in last month
Before 14 June 2024 0% 0% 0% 0%
Between 14 June 2024 and 13 December 2024 0.64% 0% +0.04% +0.04%
Not before 14 December 2024 99.36% 0% -0.04% -0.04%

Sign up or sign in to forecast!

Sign Up Sign In
Files
Tip: Mention someone by typing @username